Teladoc Health Inc (NYSE:TDOC) Insider Sells $40,500.00 in Stock

Teladoc Health Inc (NYSE:TDOC) insider Lewis Levy sold 675 shares of the firm’s stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $60.00, for a total transaction of $40,500.00. Following the transaction, the insider now owns 4,805 shares of the company’s stock, valued at approximately $288,300. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Lewis Levy also recently made the following trade(s):

  • On Monday, June 3rd, Lewis Levy sold 675 shares of Teladoc Health stock. The stock was sold at an average price of $58.00, for a total transaction of $39,150.00.
  • On Wednesday, May 1st, Lewis Levy sold 2,025 shares of Teladoc Health stock. The stock was sold at an average price of $60.00, for a total transaction of $121,500.00.
  • On Thursday, April 11th, Lewis Levy sold 675 shares of Teladoc Health stock. The stock was sold at an average price of $56.80, for a total transaction of $38,340.00.

Shares of Teladoc Health stock opened at $63.50 on Friday. The company has a debt-to-equity ratio of 0.42, a current ratio of 7.54 and a quick ratio of 7.54. Teladoc Health Inc has a fifty-two week low of $42.08 and a fifty-two week high of $89.05.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Tuesday, April 30th. The health services provider reported ($0.43) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.01. The business had revenue of $128.57 million during the quarter, compared to analyst estimates of $127.99 million. Teladoc Health had a negative net margin of 22.63% and a negative return on equity of 10.86%. Teladoc Health’s revenue for the quarter was up 43.4% compared to the same quarter last year. During the same quarter last year, the business posted ($0.39) earnings per share. On average, equities analysts predict that Teladoc Health Inc will post -1.53 EPS for the current fiscal year.

TDOC has been the subject of several recent analyst reports. Cantor Fitzgerald reaffirmed a “hold” rating and set a $70.00 price objective (down previously from $83.00) on shares of Teladoc Health in a report on Wednesday, February 27th. SunTrust Banks raised their price objective on shares of Teladoc Health to $75.00 and gave the stock a “positive” rating in a report on Monday, March 4th. Zacks Investment Research lowered shares of Teladoc Health from a “hold” rating to a “sell” rating in a report on Friday, March 8th. Stephens initiated coverage on shares of Teladoc Health in a report on Tuesday, April 16th. They set an “overweight” rating and a $75.00 price objective for the company. Finally, Guggenheim initiated coverage on shares of Teladoc Health in a report on Wednesday, April 17th. They set a “buy” rating for the company. Three analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $82.68.

Several institutional investors have recently modified their holdings of TDOC. Vanguard Group Inc increased its holdings in shares of Teladoc Health by 26.9% in the third quarter. Vanguard Group Inc now owns 5,874,182 shares of the health services provider’s stock valued at $507,236,000 after purchasing an additional 1,244,388 shares in the last quarter. Rhumbline Advisers increased its holdings in shares of Teladoc Health by 49.9% in the fourth quarter. Rhumbline Advisers now owns 89,859 shares of the health services provider’s stock valued at $4,454,000 after purchasing an additional 29,905 shares in the last quarter. State Board of Administration of Florida Retirement System increased its holdings in shares of Teladoc Health by 2.1% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 33,905 shares of the health services provider’s stock valued at $1,681,000 after purchasing an additional 689 shares in the last quarter. Enlightenment Research LLC acquired a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $25,000. Finally, Penserra Capital Management LLC acquired a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $83,000.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: What is an investor looking for in an SEC filing?

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.